Statistical analyses of our data suggest that TNFAIP3 loss and MYD88 mutations are positively correlated in DLBCL (p = 0.017), but not WM (p = 1.0) WM, although our sample size was small. The gene discussed is MYD88; the disease is diffuse large B-cell lymphoma.